MeiraGTx Holdings PLC

MGTX Healthcare Biotechnology

MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024.

Revenue
+8,608.6%
EPS
+466.7%
Free cash flow
+13.1%
Total debt
+28.6%

Quarter to June 2026, against a year earlier

8.99 0.48 +5.64%
Market cap
$817.3M
P/E
11.8×
Fwd P/E
30.3×
Dividend yield
—
F-score
5/9
Altman Z
−4.39
Beneish M
−3.01
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
72.22% 963.07% (368.19%) (611.42%)

+8 more TTM periods

Piotroski F-Score
6 6 5 4
ROA
26.54% (51.44%) (44.42%) (69.00%)
ROIC
66.60% 0.00% 0.00% 0.00%
Return on Tangible Assets
30.31% (532.23%) (152.94%) 1,520.40%
Average Days of Receivables
40.64 82.19 82.00 157.23
Free Cash Flow per Share
0.11 0.05 (0.62) (1.49)
Free Cash Flow
10.12 4.28 (50.06) (120.50)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 25 Oct 2026